|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Merck KGaA: PharmaVitae Profile
Analysis of Merck KGaA’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013
Genzyme Corporation: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Genzyme in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa
Eisai Co., Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Eisai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale
AstraZeneca plc (incl. MedImmune Inc.): PharmaVitae Profile
This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 yea
Menarini: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Menarini in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Pfizer Inc.: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Pfizer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Biogen Idec Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Biogen Idec in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 yea
Genentech: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Genentech in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year
Shionogi & Co., Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Shionogi in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
H. Lundbeck A/S: PharmaVitae Profile
This analysis examines the historical and forecast performance for Lundbeck in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Sepracor Inc.: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Sepracor in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Amgen Inc.: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Amgen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale
Forest Laboratories Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Forest in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Menarini: PharmaVitae Profile 2008
This analysis examines the historical and forecast performance for Menarini in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Bayer Schering Pharma AG: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Bayer Schering in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Nycomed A/S (incl. Altana Pharma AG): PharmaVitae Profile
This analysis examines the historical and forecast performance for Nycomed in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa
Solvay: PharmaVitae Profile
This analysis examines the historical and forecast performance for Solvay in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Sanofi-Aventis: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Sanofi-Aventis in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
|
